Amyotrophic lateral sclerosis (ALS) market refers to the global commercial landscape focused on the development, approval and delivery of treatments and supportive care for ALS, a progressive neurodegenerative disease that affects motor neurons leading to muscle weakness, paralysis and ultimately respiratory failure. The market includes small-molecule drugs, gene and cell therapies, symptomatic treatments and supportive care solutions, driven by scientific research, regulatory approvals and collaborations between biotech and pharmaceutical companies to address the unmet medical needs of ALS patients worldwide.